2 news items
Sol-Gel Reports First Quarter 2024 Financial Results and Provides Corporate Updates
SLGL
20 May 24
long
Sol-Gel and Beimei Pharma Announce an Asset Purchase Agreement to Commercialize TWYNEO® in the Mainland of China, Hong Kong, Macau, Taiwan and Israel
SLGL
16 May 24
. Beimei Pharma has established long-term partnerships with multiple large international pharmaceutical companies, such as Hetero, Cipla, Deva, Dr
- Prev
- 1
- Next